PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
摘要:
The present disclosure relates to the use of ADCs comprising anti-CD25 antibodies for in treating disorders characterized by the presence of CD25+ve cells.
信息查询
0/0